NasdaqGS - Nasdaq Real Time Price USD

United Therapeutics Corporation (UTHR)

Compare

279.69

-12.03

(-4.12%)

At close: April 8 at 4:00:00 PM EDT

280.00

+0.31

+(0.11%)

Pre-Market: 6:39:18 AM EDT

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 18 hours ago

UTHR
-4.12%
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United Therapeutics (NASDAQ:UTHR).

StockStory 2 days ago

UTHR
-4.12%
BMRN
-5.53%
MRNA
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that ten posters and presentations across its commercial and development portfolio will be presented at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting and Scientific Sessions taking place April 27 through April 30, 2025 in Boston.

Business Wire 4 days ago

UTHR
-4.12%
United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 02, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place to Work® and Fortune magazine recognized the company as one of the Fortune 100 Best Companies to Work For® in 2025. United Therapeutics ranked number 73 out of the 100 companies across the nation included in the list.

Business Wire 6 days ago

UTHR
-4.12%
Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry […]

Insider Monkey 6 days ago

UTHR
-4.12%
Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader market […]

Insider Monkey 11 days ago

UTHR
-4.12%
COMP
United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 11 days ago

UTHR
-4.12%
ZTS
3 Reasons Investors Watch United Therapeutics (UTHR)

Over the last six months, United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

StockStory 12 days ago

UTHR
-4.12%
Investing Action Plan: Anduril Industries, United Therapeutics, Barstool In Miami

The stock market is waiting on a follow through day. Miami's eMerge Americas conference may provide some surprise energy for the week.

Investor's Business Daily 18 days ago

MCK

GE

UTHR
-4.12%
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

StockStory 20 days ago

BIIB

BMRN
-5.53%
MRNA
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.4%. This performance was disappointing since the S&P 500 held its ground.

StockStory 21 days ago

CHE

UTHR
-4.12%
Is United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment?

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best healthcare stocks for long-term investment. Rising Healthcare Costs and the Impact of Tariffs on the US Industry In the US, healthcare expenditures […]

Insider Monkey 25 days ago

UTHR
-4.12%
2 Value Stocks on Our Watchlist and 1 to Ignore

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

StockStory 27 days ago

UTHR
-4.12%
DHI
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s operations during a fireside chat session at the Leerink Partners Global Healthcare Conference 2025 in Miami Beach.

Business Wire last month

UTHR
-4.12%
United Therapeutics price target lowered to $420 from $430 at Leerink

Leerink analyst Roanna Ruiz lowered the firm’s price target on United Therapeutics (UTHR) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics’ Q4 earnings brought clarity on the outlook for the base commercial business and Tyvaso’s future growth trajectory, suggesting that gross-to-net impact from recent contracting efforts for the Tyvaso franchise should be largely baked in going forward, the analyst tells investors in a research note. The firm adds that Q4 could

TipRanks last month

UTHR
-4.12%
United Therapeutics Corp (UTHR) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

United Therapeutics Corp (UTHR) reports a third consecutive year of record revenue, strategic clinical advancements, and significant shareholder returns.

GuruFocus.com last month

UTHR
-4.12%
Q4 2024 United Therapeutics Corp Earnings Call

Q4 2024 United Therapeutics Corp Earnings Call

Thomson Reuters StreetEvents last month

UTHR
-4.12%
Why United Therapeutics (UTHR) Stock Is Down Today

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts' expectations, and sales were underwhelming, coming in line with expectations. We struggled to find many positives in these results, especially because EPS missed. Overall, this quarter could have been better.

StockStory last month

UTHR
-4.12%
United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat

UTHR beats fourth-quarter estimates for both earnings and sales. Tyvaso sales fall short of estimates. Stock down in pre-market trading.

Zacks last month

UTHR
-4.12%
United Therapeutics (UTHR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks last month

UTHR
-4.12%

Performance Overview

Return	UTHR	S&P 500 (^GSPC)
YTD	-20.73%	-15.28%
1-Year	+18.03%	-4.22%
3-Year	+47.77%	+11.02%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

United Therapeutics Corporation (UTHR)

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?

Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?

United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?

3 Reasons Investors Watch United Therapeutics (UTHR)

Investing Action Plan: Anduril Industries, United Therapeutics, Barstool In Miami

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

Is United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment?

2 Value Stocks on Our Watchlist and 1 to Ignore

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

United Therapeutics price target lowered to $420 from $430 at Leerink

United Therapeutics Corp (UTHR) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Q4 2024 United Therapeutics Corp Earnings Call

Why United Therapeutics (UTHR) Stock Is Down Today

United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat

United Therapeutics (UTHR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Performance Overview